CELLDEX
associated with 30 other trademarks
use as a housemark for Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of c...

Words that describe this trademark:

monoclonal antibodies treatment  treatment cancer  antibodies treatment  therapeutic pharmaceuticals  therapeutic vaccines  derived  vaccines  housemark  pharmaceuticals 

Serial Number:

78397614

Mark:

CELLDEX

Status:

Abandoned-No Statement of Use filed

Status Date:

03-28-2007

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

use as a housemark for Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disorders, infectious diseases and graft-verus-host disease

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

01-18-2005

Mark Drawing Status:

Standart Character Mark

Abandon Date:

03-28-2007

Business Name:

SATTERLEE STEPHENS BURKE & BURKE LLP

Correspondent Name:

Recent Trademark filings by this company